StockData

Jyong Biotech Ltd. (MENS) stock

MENSNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 0/30
$1.86+0.06 (+3.33%)

Close on Nov 18, 2026Market cap $141.41MP/E –Yield –

Jyong Biotech r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $813.00K, down 12.3% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$813.00K-12.3%
FY2024Dec 31, 2024$927.00K-13.4%
FY2023Dec 31, 2023$1.07M–

More Jyong Biotech figures

See a number that looks wrong?